Professional Documents
Culture Documents
CredibleMeds: OncoSupport™ For Oncology Prescribing
CredibleMeds: OncoSupport™ For Oncology Prescribing
03/01/17 20:26
OncoSupport
The following medications are often used to treat patients with cancer and are currently listed in one of
CredibleMeds three TdP risk categories (category icons defined below):
Anti-cancer Medicine
Anti-Nausea
Antidepressants
Anesthetics
Arsenic trioxide
Chlorpromazine
Amitriptyline
Cocaine
Bortezomib
Dolasetron
Aripiprazole
Droperidol
Bosutinib
Domperidone
Citalopram
Propofol
Capecitabine
Droperidol
Clomipramine
Sevoflurane
Ceritinib
Granisetron
Desipramine
Crizotinib
Metoclopramide
Doxepin
Dabrafenib
Ondansetron
Escitalopram
Dasatinib
Promethazine
Fluoxetine
Degarelix
Tropisetron
Fluvoxamine
Eribulin mesylate
Imipramine (melipramine)
Lapatinib
Mirtazapine
Lenvatinib
Nortriptyline
Leuprolide
Paroxetine
Nilotinib
Sertraline
Osimertinib
Trazodone
Oxaliplatin
Trimipramine
Pazopanib
Venlafaxine
Sorafenib
Sunitinib
Tamoxifen
Toremifene
https://crediblemeds.org/oncosupport/
Pagina 1 di 2
03/01/17 20:26
Vandetanib
Vemurafenib
Vorinostat
Known Risk of TdP - Substantial evidence supports the conclusion that these drugs prolong the QT interval AND are clearly associated
with a risk of TdP, even when taken as directed in official labeling.
Possible Risk of TdP - Substantial evidence supports the conclusion that these drugs can cause QT prolongation BUT there is
insufficient evidence at this time that these drugs, when used as directed in official labeling, are associated with a risk of causing TdP.
Conditional Risk of TdP - Substantial evidence supports the conclusion that these drugs are associated with a risk of TdP BUT only
under certain conditions (e.g. excessive dose, hypokalemia, congenital long QT or by causing a drug-drug interaction that results in
excessive QT interval prolongation)
info@azcert.org
520-989-0900
https://crediblemeds.org/oncosupport/
Pagina 2 di 2